Advertisement

Clinical Drug Investigation

, Volume 39, Issue 1, pp 115–115 | Cite as

Correction to: Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

  • Sermsiri Sangroongruangsri
  • Usa ChaikledkaewEmail author
  • Suthasinee Kumluang
  • Olivia Wu
  • Claudia Geue
  • Tanapat Ratanapakorn
  • Pattara Leelahavarong
  • Lily Ingsrisawang
  • Paisan Ruamviboonsuk
  • Wongsiri Taweebanjongsin
  • Janejit Choovuthayakorn
  • Apichart Singalavanija
  • Prut Hanutsaha
  • Kittisak Kulvichit
  • Thitiporn Ratanapojnard
  • Warapat Wongsawad
  • Yot Teerawattananon
Open Access
Correction
  • 142 Downloads

1 Correction to: Clinical Drug Investigation (2018) 38:853–865  https://doi.org/10.1007/s40261-018-0678-5

The Open Access license, which previously read:

Open Access

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Should read:

Open Access

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

The original article has been corrected.

Copyright information

© The Author(s) 2019

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Sermsiri Sangroongruangsri
    • 1
  • Usa Chaikledkaew
    • 1
    Email author
  • Suthasinee Kumluang
    • 2
  • Olivia Wu
    • 3
  • Claudia Geue
    • 3
  • Tanapat Ratanapakorn
    • 4
  • Pattara Leelahavarong
    • 2
  • Lily Ingsrisawang
    • 5
  • Paisan Ruamviboonsuk
    • 6
  • Wongsiri Taweebanjongsin
    • 7
  • Janejit Choovuthayakorn
    • 8
  • Apichart Singalavanija
    • 9
  • Prut Hanutsaha
    • 10
  • Kittisak Kulvichit
    • 11
  • Thitiporn Ratanapojnard
    • 12
  • Warapat Wongsawad
    • 7
  • Yot Teerawattananon
    • 2
  1. 1.Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of PharmacyMahidol UniversityBangkokThailand
  2. 2.Health Intervention and Technology Assessment ProgramMinistry of Public HealthNonthaburiThailand
  3. 3.Institute of Health and WellbeingUniversity of GlasgowGlasgowUK
  4. 4.Department of OphthalmologyKhon Kaen UniversityKhon KaenThailand
  5. 5.Department of Statistics, Faculty of ScienceKasetsart UniversityBangkokThailand
  6. 6.Department of Ophthalmology, Faculty of Medicine, Rajavithi HospitalRangsit UniversityBangkokThailand
  7. 7.Mettapracharak Eye InstituteMettapracharak (Wat Rai Khing) HospitalNakhon PathomThailand
  8. 8.Department of Ophthalmology, Faculty of MedicineChiang Mai UniversityChiang MaiThailand
  9. 9.Department of Ophthalmology, Faculty of Medicine Siriraj HospitalMahidol UniversityBangkokThailand
  10. 10.Department of Ophthalmology, Ramathibodi HospitalMahidol UniversityBangkokThailand
  11. 11.Department of Ophthalmology, Faculty of MedicineChulalongkorn UniversityBangkokThailand
  12. 12.Department of Ophthalmology, Phramongkutklao HospitalPhramongkutklao College of MedicineBangkokThailand

Personalised recommendations